Literature DB >> 22034649

Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.

Marc Miravitlles1, Frank Kruesmann, Daniel Haverstock, Renee Perroncel, Shurjeel H Choudhri, Pierre Arvis.   

Abstract

We examined the correlation between sputum colour and the presence of potentially pathogenic bacteria in acute exacerbations of chronic bronchitis (AECBs). Data were pooled from six multicentre studies comparing moxifloxacin with other antimicrobials in patients with an AECB. Sputum was collected before antimicrobial therapy, and bacteria were identified by culture and Gram staining. Association between sputum colour and bacteria was determined using logistic regression. Of 4,089 sputum samples, a colour was reported in 4,003; 1,898 (46.4%) were culture-positive. Green or yellow sputum samples were most likely to yield bacteria (58.9% and 45.5% of samples, respectively), compared with 18% of clear and 39% of rust-coloured samples positive for potentially pathogenic microorganisms. Factors predicting a positive culture were sputum colour (the strongest predictor), sputum purulence, increased dyspnoea, male sex and absence of fever. Green or yellow versus white sputum colour was associated with a sensitivity of 94.7% and a specificity of 15% for the presence of bacteria. Sputum colour, particularly green and yellow, was a stronger predictor of potentially pathogenic bacteria than sputum purulence and increased dyspnoea in AECB patients. However, it does not necessarily predict the need for antibiotic treatment in all patients with AECB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034649     DOI: 10.1183/09031936.00042111

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  Sputum purulence-associated microbial community compositions in adults with bronchiectasis.

Authors:  Wei-Jie Guan; Yan Huang; Chun-Lan Chen; Jing-Jing Yuan; Hui-Min Li; Yong-Hua Gao; Rong-Chang Chen; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.

Authors:  Yan-Ping Ye; Hang Zhao; Tao Kang; Li-Hua Zhao; Ning Li; Jing Chen; Xiao-Xia Peng
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

3.  Previous outpatient antibiotic use in patients admitted to hospital for COPD exacerbations: room for improvement.

Authors:  M Miravitlles; J J Soler-Cataluña; F Baranda; P Cordero; J-V Greses; C de la Roza
Journal:  Infection       Date:  2012-08-21       Impact factor: 3.553

4.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

5.  C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.

Authors:  Miguel Gallego; Xavier Pomares; Silvia Capilla; Maria Angeles Marcos; David Suárez; Eduard Monsó; Concepción Montón
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-21

6.  Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.

Authors:  S Sethi; A Anzueto; M Miravitlles; P Arvis; J Alder; D Haverstock; M Trajanovic; R Wilson
Journal:  Infection       Date:  2015-09-14       Impact factor: 3.553

Review 7.  Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Mol Sci       Date:  2017-06-23       Impact factor: 5.923

Review 8.  Acute exacerbations of COPD: risk factors for failure and relapse.

Authors:  Marco Mantero; Paola Rogliani; Marta Di Pasquale; Eva Polverino; Ernesto Crisafulli; Monica Guerrero; Andrea Gramegna; Mario Cazzola; Francesco Blasi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-08

9.  Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.

Authors:  Carl Llor; Ana Moragas; Carolina Bayona; Rosa Morros; Helena Pera; Oleguer Plana-Ripoll; Josep M Cots; Marc Miravitlles
Journal:  BMJ       Date:  2013-10-04

Review 10.  Pulmonary biomarkers in COPD exacerbations: a systematic review.

Authors:  Angela Koutsokera; Konstantinos Kostikas; Laurent P Nicod; Jean-William Fitting
Journal:  Respir Res       Date:  2013-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.